GE bets on Latin American growth with Brazilian plant
This article was originally published in Clinica
Executive Summary
GE Healthcare is on course to open in 2010 its first manufacturing plant in Latin America, with the aim of introducing a diagnostic product range tailored to the region. The project, part of GE's global US$6bn Healthymagination programme (see Clinica No 1340, p 1), testifies to the company's expectation of significant market growth across the region.
You may also be interested in...
Purespring Therapeutics: Pioneering Gene Therapy For Kidney Disorders
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Pioneers Posaconazole And Silodosin In Canada
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
Amarin Pulls Insurer Into Hikma/Vascepa Induced Infringement Suit
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: